Stock INTI INHIBITOR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Inhibitor Therapeutics, Inc.

Equities

INTI

US45720M1053

Market Closed - OTC Markets
Other stock markets
 19:00:48 04/06/2024 BST 		5-day change 1st Jan Change
0.0701 USD -19.98% Intraday chart for Inhibitor Therapeutics, Inc. -34.97% -23.80%
05-13 Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-29 Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INHIBITOR THERAPEUTICS, INC. Stock Inhibitor Therapeutics, Inc.
 15.1M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.82B -
ARGENX SE Stock argenx SE
 22.48B -
GENMAB A/S Stock Genmab A/S
 18.32B
  1. Stock Market
  2. Equities
  3. INTI Stock
  4. Charts Inhibitor Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW